Table 4 Hazard ratios of survival

From: Peptide receptor radionuclide therapy with 90Y-DOTATATE/90Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity

  

95% CI

 

Variable

HR

Lower

Upper

P-value

Univariate Cox regression

Radiological group

0.24

0.10

0.57

0.0010

Clinical group

0.47

0.19

1.14

0.0940

Biochemistry group

0.55

0.20

1.52

0.2520

CgA (100 unit change)

1.18

1.06

1.30

0.0020

Age

1.03

0.98

1.08

0.3020

Multivariable Cox regression

Variable

HR

Lower

Upper

P -value

Radiological group

0.19

0.07

0.50

0.001

CgA (per 100 units)

1.17

1.04

1.32

0.011

Age

0.99

0.93

1.05

0.657

  1. Abbreviation: CI=confidence interval; HR=hazard ratio.